Oncotarget

Research Papers:

Sialylated immunoglobulin G can neutralize influenza virus infection through receptor mimicry

Tao Huang _, Xueling Chen, Conghui Zhao, Xingmu Liu, Zaiping Zhang, Tongfei Li, Ruiman Sun, Huan Gu and Jiang Gu

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:15606-15617. https://doi.org/10.18632/oncotarget.7244

Metrics: PDF 8011 views  |   HTML 1112 views  |   ?  


Abstract

Tao Huang1,*, Xueling Chen1,*, Conghui Zhao2,3, Xingmu Liu1,4, Zaiping Zhang1, Tongfei Li1, Ruiman Sun1, Huan Gu1, Jiang Gu1,3

1Department of Pathology and Provincial Key Laboratory of Infectious Diseases and Immunopathology, Collaborative and Creative Center, Shantou University Medical College, Shantou, Guangdong, 515041, China

2Department of Oral Pathology, Beijing Stomatological Hospital, Capital Medical University, Beijing, 100050, China

3Department of Pathology, Beijing University Health Science Center, Beijing, 100083, China

4Department of General Surgery, Second Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, 515041, China

*These authors have contributed equally to this work

Correspondence to:

Jiang Gu, e-mail: 2523381625@qq.com

Keywords: IVIG, sialylation, influenza virus, neutralizing activity, receptor

Received: October 24, 2015    Accepted: January 24, 2016    Published: February 08, 2016

ABSTRACT

Influenza viruses possess a great threat to human health, but there is still no effective drug to deal with the outbreak of possible new influenza subtypes. In this study, we first fractionated sialylated immunoglobulin G (IgG), mainly Fab sialylated fraction, with sambucus nigra agglutinin affinity chromatography. We then demonstrated that sialylated IgG possessed more effective neutralizing activity against 2009 A (H1N1) subtype than that of IgG mixture, and sialosides on the Fab is crucial in this neutralization reaction as when such residues were removed with neuraminidase A digestion the blocking effect was significantly reduced. It appears that sialic acid residues attached to Fab could serve as binding moieties to receptor binding site of influenza virus. These findings indicate that sialylated IgG probably is an effective anti-influenza broad-spectrum drug utilizing its receptor mimicry to competitively inhibit the attachment of influenza viruses with sialic acid receptors on target cells. This property would be particularly useful if it can be applied to prevent newly emerged influenza virus strain infections in future epidemics.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 7244